Chem (Sodium Polystyrene Sulfonate Suspension Usp 1)
Sodium Polystyrene Sulfonate Suspension
Product Images NDC 35573-108
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sodium Polystyrene Sulfonate (NDC 35573-108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Burel Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Carton (Sodium Polystyrene Sulfonate Suspension Usp 2)
This is a description for a medication named Sodium Polystyrene Sulfonate Suspension, USP. It is used for the treatment of high levels of potassium in the blood.*
Pint (Sodium Polystyrene Sulfonate Suspension Usp 3)
This is a description of a medication called Sodium Polystyrene Sulfonate Suspension, USP, indicated for oral or rectal use. Each 60 mL of the suspension contains 15 g of Sodium Polystyrene Sulfonate USP, along with other ingredients such as Propylene Glycol USP and Xanthan Gum. The sodium content is 1.5 g (65 mEq) in 60 mL. The usual dose should be followed as per the package insert. The medication should be stored at 20°-25°C (68°-77°F) with excursions allowed between 15°-30°C (59°-86°F). It needs to be dispensed in a tight container as per USP standards. This medication is manufactured by Burel Pharmaceuticals LLC in Mason, OH, USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
